A series of new benzothiazole derivatives containing dimethylpyrazole were synthesized and evaluated for their anticonvulsant activity, neurotoxicity and cytotoxicity by using the maximal electroshock (MES), rotarod neurotoxicity (TOX) and MTT colorimetric assay. Among the compounds studied, four compounds (6a, 6b, 6g and 6m) showed better anticonvulsant than the others at 300 mg/kg and they also showed anticonvulsant activity at the dose of 100 mg/kg. All the synthetic compounds showed lower neurotoxicity and little cytotoxicity, so that the compounds, which with better activities, also had higher protective index. In particular, the compound 6g, 2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-((2-fluorobenzyl)oxy)benzo[d]thiazole showed better activity with an ED50 value of 160.4 mg/kg and higher protective index (PI) values of 2.74 in the MES test than the standard drugs sodium valproate, which used as positive controls in this study. After that the compound 6g demonstrated antagonistic activity against seizures induced by pentylenetetrazol, which proved 6g maybe exert activity through effecting GABAergic neurotransmission.
Liu, D., Cheng, X., & Wang, Y. (2019). Design, Synthesis and Biological Evaluation of Benzo[D]Thiazole with Dimethylpyrazol Derivatives. Asian Pacific Journal of Cancer Prevention, 20(11), 3487-3495. doi: 10.31557/APJCP.2019.20.11.3487
MLA
Dachuan Liu; Xiu Cheng; Ying Wang. "Design, Synthesis and Biological Evaluation of Benzo[D]Thiazole with Dimethylpyrazol Derivatives". Asian Pacific Journal of Cancer Prevention, 20, 11, 2019, 3487-3495. doi: 10.31557/APJCP.2019.20.11.3487
HARVARD
Liu, D., Cheng, X., Wang, Y. (2019). 'Design, Synthesis and Biological Evaluation of Benzo[D]Thiazole with Dimethylpyrazol Derivatives', Asian Pacific Journal of Cancer Prevention, 20(11), pp. 3487-3495. doi: 10.31557/APJCP.2019.20.11.3487
VANCOUVER
Liu, D., Cheng, X., Wang, Y. Design, Synthesis and Biological Evaluation of Benzo[D]Thiazole with Dimethylpyrazol Derivatives. Asian Pacific Journal of Cancer Prevention, 2019; 20(11): 3487-3495. doi: 10.31557/APJCP.2019.20.11.3487
)